Causeway Capital Management LLC Abb Vie Inc. Transaction History

Causeway Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$159.82 - $182.1 $30.2 Million - $34.5 Million	-189,253 Reduced 46.98%	213,613 $38.9 Million
Q4 2023 Feb 14, 2024	BUY	$137.6 - $154.97 $781,980 - $880,694	5,683 Added 1.43%	402,866 $62.4 Million
Q3 2023 Nov 09, 2023	BUY	$133.59 - $154.65 $7.76 Million - $8.99 Million	58,123 Added 17.14%	397,183 $59.2 Million
Q2 2023 Aug 11, 2023	BUY	$132.51 - $164.9 $44.9 Million - $55.9 Million	339,060 New	339,060 $45.7 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Causeway Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Causeway Capital Management LLC with notifications on news.